[HTML][HTML] Características clínicas de los pacientes hospitalizados con COVID-19 en España: resultados del Registro SEMI-COVID-19

JM Casas-Rojo, JM Antón-Santos… - Revista Clínica …, 2020 - Elsevier
Antecedentes España ha sido uno de los países más afectados por la pandemia de COVID-19.
Objetivo Crear un registro de pacientes hospitalizados en España por COVID-19 para …

Clinical characteristics and risk factors for mortality in very old patients hospitalized with COVID-19 in Spain

…, C Pérez-García, JM Casas-Rojo… - The Journals of …, 2021 - academic.oup.com
Background Advanced age is a well-known risk factor for poor prognosis in COVID-19.
However, few studies have specifically focused on very old inpatients with COVID-19. This study …

[HTML][HTML] Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry …

…, R Gómez Huelgas, JM Casas Rojo… - PloS one, 2021 - journals.plos.org
Background Most patients with COVID-19 receive antibiotics despite the fact that bacterial co-infections
are rare. This can lead to increased complications, including antibacterial …

[HTML][HTML] Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy

…, P Cubero-Morais, JM Casas-Rojo… - BMC infectious …, 2021 - Springer
Background Since December 2019, the COVID-19 pandemic has changed the concept of
medicine. This work aims to analyze the use of antibiotics in patients admitted to the hospital …

[HTML][HTML] Association of hypertension with all-cause mortality among hospitalized patients with COVID-19

…, AL Martinez-Gonzalez, JM Casas-Rojo… - Journal of clinical …, 2020 - mdpi.com
It is unclear to which extent the higher mortality associated with hypertension in the
coronavirus disease (COVID-19) is due to its increased prevalence among older patients or to …

[HTML][HTML] WHO ordinal scale and inflammation risk categories in COVID-19. Comparative study of the severity scales

…, J Millán Núñez-Cortés, JM Casas-Rojo… - Journal of general …, 2022 - Springer
Background The WHO ordinal severity scale has been used to predict mortality and guide
trials in COVID-19. However, it has its limitations. Objective The present study aims to …

Admission inferior vena cava measurements are associated with mortality after hospitalization for acute decompensated heart failure

…, R González‐Davia, JM CasasRojo… - Journal of hospital …, 2016 - Wiley Online Library
BACKGROUND Prognostication of patients hospitalized with acute decompensated heart
failure (ADHF) is important to patients, providers, and healthcare systems. Few bedside tools …

[HTML][HTML] Risk categories in COVID-19 based on degrees of inflammation: data on more than 17,000 patients from the Spanish SEMI-COVID-19 Registry

…, J Millán Núñez-Cortés, JM Casas-Rojo… - Journal of Clinical …, 2021 - mdpi.com
(1) Background: The inflammation or cytokine storm that accompanies COVID-19 marks the
prognosis. This study aimed to identify three risk categories based on inflammatory …

Cardiometabolic therapy and mortality in very old patients with diabetes hospitalized due to COVID-19

…, H Meijide Míguez, JM Casas-Rojo… - The Journals of …, 2021 - academic.oup.com
Background The effects of cardiometabolic drugs on the prognosis of diabetic patients with
COVID-19, especially very old patients, are not well known. This work was aimed to analyze …

COVID‐19 vaccines reduce mortality in hospitalized patients with oxygen requirements: Differences between vaccine subtypes. A multicontinental cohort study

…, R Gómez‐Huelgas, JM CasasRojo… - Journal of Medical …, 2023 - Wiley Online Library
The aim of this study was to analyze whether the coronavirus disease 2019 (COVID‐19)
vaccine reduces mortality in patients with moderate or severe COVID‐19 disease requiring …